论文部分内容阅读
建国以来,我国通过仿制国外新药建立了一套比较完整的医药工业体系,使我国跻身于世界制药工业大国的行列。今后一个时期,我国医药工业实现品种更新换代在很大程度上仍然要依靠仿制。但是,随着国内医药工业的不断发展及人民用药水平的改善和提高,仿制新药的任务和重心与过去相比已有很大的不同。而且,随着国外新药研究发展方向的调整和变化,也要求我们在仿制工作上要有一些新的思路和变化,提高仿制投入的效益。1 国内外医药研究发展趋势进入80年代以来,人们已经可以清楚地看到世界新药研究开发正在发生的深刻变化,主要表现在新药上市的数量及其结构两
Since the founding of New China, our country has established a relatively complete system of pharmaceutical industry through the imitation of new foreign drugs, making our country one of the largest pharmaceutical industrial countries in the world. In the coming period, the upgrading of China’s pharmaceutical industry to a large extent will still depend on imitation. However, with the continuous development of the domestic pharmaceutical industry and the improvement and improvement of people’s medication standards, the tasks and priorities of the new generic drugs have been greatly different from the past. Moreover, with the adjustment and change in the direction of the development of new drug research in foreign countries, we also demand that we have some new ideas and changes in the work of imitation to improve the efficiency of generic investment. 1 Trends in the Development of Medical Research at Home and Abroad Since the 1980s, people have been able to clearly see that profound changes are taking place in the research and development of new drugs in the world. The changes are mainly reflected in the number of new drugs listed and their structure